Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.
| Author | |
|---|---|
| Abstract |
:
In the primary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) trial, now published in the Journal, we report that the daily use of aspirin did not provide a benefit with regard to the primary end point of disability-free survival among older adults. A numerically higher rate of the secondary end point of death from any cause was observed with aspirin than with placebo. |
| Year of Publication |
:
2018
|
| Journal |
:
The New England journal of medicine
|
| Volume |
:
379
|
| Issue |
:
16
|
| Number of Pages |
:
1519-1528
|
| Date Published |
:
2018
|
| ISSN Number |
:
0028-4793
|
| URL |
:
https://www.nejm.org/doi/10.1056/NEJMoa1803955?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov
|
| DOI |
:
10.1056/NEJMoa1803955
|
| Short Title |
:
N Engl J Med
|
| Download citation |
